Your session is about to expire
← Back to Search
Sedentary RE for Physical Activity (MoTrPAC Trial)
MoTrPAC Trial Summary
This trial is looking at how physical activity affects the body at a molecular level.
MoTrPAC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMoTrPAC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MoTrPAC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have reported lung problems.I have a bone condition that affects how my bones use minerals.I have been infected with COVID-19.I have experienced abnormal bleeding or have a bleeding disorder.I have an autoimmune disorder.People who exercise casually are allowed in the study, as long as they don't experience certain levels of heart rate, breathing, and sweating during the study.I have been diagnosed with cancer.I am 18 years old or older.I am 18 years old or older.I have diabetes.I have long-term kidney problems.I haven't changed the dose of any long-term medications in the last 3 months.I have a long-term active or hidden infection.I have used lidocaine or another local anesthetic.I am currently taking estrogen or progestin medications.I have been taking a new medication for at least 7 days in the past 3 months.Adults who are very physically active and meet the study's requirements.If you ride a bike to work at least once a week, you are not considered sedentary.My BMI is between 19 and 35.You have not engaged in regular physical activity, such as brisk walking or jogging, for more than an hour once a week in the past year.I am an adult who does not exercise regularly.Your body mass index (BMI) falls between 19 and 35 kg/m2.
- Group 1: Highly Active EE
- Group 2: Sedentary RE
- Group 3: Highly Active RE
- Group 4: Sedentary control
- Group 5: Sedentary EE
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent can the participant numbers for this experiment reach?
"To fulfil the requirements of this clinical trial, 2,280 volunteers who meet its criteria must be recruited. These individuals can participate in East Carolina University (Greenville, NC) and Ball State University (Muncie IN)."
What aims has this research endeavor set out to realize?
"During this trial period, which will encompass the Baseline and Week 12 points in time, our primary objective is to investigate Metabolome within muscle tissue. Additionally, we are looking into changes of Transcriptome levels in blood plasma, Proteome variations among plasma proteins, as well as any alterations regarding Metabolite concentrations found in said liquid sample."
How many clinical centers are participating in this trial?
"Presently, nine different medical sites are hosting this trial; for example, Greenville, Muncie and San Antonio. To minimize travel requirements it may be beneficial to choose the nearest option if you decide to sign up."
Are new participants being enrolled in this clinical investigation currently?
"As per clinicaltrials.gov, this medical trial is currently seeking participants. It was initially posted on August 28th 2019 and recently updated on October 11 2021."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger